Elixirgen Scientific
Science + Technology Park at Johns Hopkins
855 N. Wolfe Street, Suite 619
Baltimore
Maryland
21205
United States
Tel: 443-869-5420
Fax: 443-708-3880
Website: https://elixirgenscientific.com/
Email: info@elixirgenscientific.com
7 articles about Elixirgen Scientific
-
Elixirgen Scientific Achieves ISO 9001 QMS Certification
3/12/2024
Baltimore-based biotechnology leader, Elixirgen Scientific, Inc., achieves ISO 9001:2015 Quality Management System certification, strengthening commitment to quality, excellence in biotechnology and drug discovery.
-
Agenus and Targovax partner on a KRAS cancer vaccine, Elixirgen and Taisho target aging and Tonix and Mass General team up again to fight kidney transplant rejection.
-
Elixirgen Therapeutics Concludes pre-IND Meeting with FDA for its COVID-19 Vaccine Candidate EXG-5003
6/4/2020
Elixirgen Therapeutics, Inc., a Baltimore -based biotechnology company focused on the discovery, development, and commercialization of therapies for genetic diseases and vaccines, announced that it concluded on May 18 its pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for the company's C
-
FDA Approves Elixirgen Therapeutics IND Application for Therapy for Telomere Biology Disorders with Bone Marrow Failure
6/4/2020
Elixirgen Therapeutics, Inc., a Baltimore -based biotechnology company focused on the discovery, development, and commercialization of therapies for genetic diseases and vaccines, received confirmation from the U.S. Food and Drug Administration (FDA) that its Investigational New Drug (IND) application for its lead candidate, EXG34217, wa
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 4, 2020.
-
Elixirgen Scientific's New Sendai Virus-based Kits Are World's Fastest At Making Neurons And Muscle
6/2/2017
-
Elixirgen Scientific Release: New Quick-Tissue Kits Revolutionize Skeletal Muscle And Neuron Differentiation
10/3/2016